(Q43950778)

28 November 2017

title

Busulphan given as four single daily doses of 150 mg/m2 is safe and effective in children of all ages (English)

1 reference

28 November 2017

Shaw PJ

1

1 reference

28 November 2017

Nath C

series ordinal

2

1 reference

28 November 2017

Berry A

series ordinal

3

1 reference

28 November 2017

Earl JW

series ordinal

4

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

Bone Marrow Transplantation

28 November 2017

published in

1 reference

28 November 2017

volume

34

1 reference

28 November 2017

issue

3

1 reference

28 November 2017

page(s)

197-205

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704560

28 November 2017

exact match

0 references

cites work

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

Marrow transplantation for thalassaemia following busulphan and cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

No convulsions in children on high-dose busulphan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

Influence of prophylactic anticonvulsant therapy on high-dose busulphan kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: study of pharmacokinetics and early clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Pharmacokinetics of oral busulphan in children with beta thalassaemia major undergoing allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Childhood acute myeloid leukemia: outcome in a single center using chemotherapy and consolidation with busulfan/cyclophosphamide for bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Application of interphase FISH on direct bone marrow smears for evidence of chimerism in pediatric sex mismatched bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Retrospective appraisal of busulfan dose adjustment in children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Busulfan pharmacokinetics do not predict relapse in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704560

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704560

1 reference

Dimensions Publication ID

28 November 2017

1032849130

0 references

1 reference